CytRx Co. (OTCMKTS:CYTR) crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $1.78 and traded as high as $2.40. CytRx shares last traded at $2.36, with a volume of 44,095 shares trading hands.
The business’s 50-day moving average is $3.46 and its 200-day moving average is $1.78.
CytRx Company Profile (OTCMKTS:CYTR)
CytRx Corporation, a biopharmaceutical company, focuses on oncology and rare diseases. It engages in the discovery, research, and clinical development of novel anti-cancer drug candidates that employ novel linker technologies to enhance the accumulation and release of cytotoxic anti-cancer agents at the tumor.
Receive News & Ratings for CytRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CytRx and related companies with MarketBeat.com's FREE daily email newsletter.